Outpatient Oncology Infusion Market Outlook:
Outpatient Oncology Infusion Market size was over USD 7.52 billion in 2025 and is projected to reach USD 18.13 billion by 2035, witnessing around 9.2% CAGR during the forecast period i.e., between 2026-2035. In the year 2026, the industry size of outpatient oncology infusion is evaluated at USD 8.14 billion.
The outpatient oncology infusion market is driven by the increasing prevalence of cancer and the corresponding rise in demand for oncology treatments. The global incidence of cancer continues to rise due to aging populations, lifestyle, and environmental factors. As more individuals are diagnosed with cancer, there is a greater need for oncology treatments, including infusion therapies administered in outpatient settings. A 2024 report published by the World Health Organization (WHO) stated that in 2022, there were about 20 million new cancer cases and 9.7 million deaths, and over 35 million new cancer cases are expected in 2050. There is a growing preference among patients and healthcare providers for outpatient care due to its cost-effectiveness, convenience, and ability to provide specialized treatments without hospitalization. This shift has led to the expansion of outpatient infusion settings specializing in oncology treatments.
